Vitamin D Replacement and Type 2 Diabetes Mellitus

被引:18
作者
Issa, Claire. M. [1 ]
Zantout, Mira S. [1 ]
Azar, Sami T. [1 ]
机构
[1] Amer Univ, Beirut Med Ctr, Div Endocrinol & Metab, Dept Internal Med, 3 Dag Hammarskjold Plaza,8th Floor, New York, NY 10017 USA
关键词
25 hydroxy vitamin D; type 2 diabetes mellitus; vitamin D replacement; 25 hydroxy vitamin D deficiency; diabetes control; diabetes complications;
D O I
10.2174/1573399811666141210153503
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The objective of this paper is to review the evidence testing the possible benefit of vitamin D replacement on diabetes control and complications. Type 2 diabetes mellitus (DM 2) has become a significant global health care problem and its reported incidence is increasing at an alarming rate. Despite the improvement in therapy and development of new drugs, treatment is still not optimal especially with the associated adverse effects of most of the available drugs. New efforts are shifted toward disease prevention and a search for safer drugs. New mounting evidence is associating low vitamin D to diabetes mellitus and as such many studies were conducted to test the effect of vitamin D replacement on incidence of diabetes, diabetes control as well as diabetes complications. Although these studies present several limitations, vitamin D replacement seems to have beneficial effect on all aspects of diabetes: incidence, control and complications. Further longer term and more powered controlled trials are necessary to draw firmer conclusions on this beneficial role of vitamin D treatment on DM.
引用
收藏
页码:7 / 16
页数:10
相关论文
共 62 条
[31]  
Looker AC, 2011, NCHS DATA BRIEF, V59, P1
[32]   Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells [J].
Maestro, B ;
Campion, J ;
Dávila, N ;
Calle, C .
ENDOCRINE JOURNAL, 2000, 47 (04) :383-391
[33]  
Mansouritorghabe H, 2013, ENDOCR METAB IMMUNE, V13, P264
[34]  
Mathieu C, 2006, AV DIABETOL, V22, P187
[35]   Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes [J].
Mattila, Catharina ;
Knekt, Paul ;
Maennistoe, Satu ;
Rissanen, Harri ;
Laaksonen, Maarit A. ;
Montonen, Jukka ;
Reunanen, Antti .
DIABETES CARE, 2007, 30 (10) :2569-2570
[36]   Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism [J].
Milliez, P ;
Girerd, X ;
Plouin, PF ;
Blacher, J ;
Safar, ME ;
Mourad, JJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (08) :1243-1248
[37]   Effects of vitamin D and calcium supplementation on pancreatic β cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial [J].
Mitri, Joanna ;
Dawson-Hughes, Bess ;
Hu, Frank B. ;
Pittas, Anastassios G. .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2011, 94 (02) :486-494
[38]   Vitamin D3 supplementation improves insulin sensitivity in subjects with impaired fasting glucose [J].
Nazarian, Shaban ;
St Peter, John V. ;
Boston, Raymond C. ;
Jones, Sidney A. ;
Mariash, Cary N. .
TRANSLATIONAL RESEARCH, 2011, 158 (05) :276-281
[39]   Daily consumption of vitamin D- or vitamin D plus calcium-fortified yogurt drink improved glycemic control in patients with type 2 diabetes: a randomized clinical trial [J].
Nikooyeh, Bahareh ;
Neyestani, Tirang R. ;
Farvid, Maryamosadat ;
Alavi-Majd, Hamid ;
Houshiarrad, Anahita ;
Kalayi, Ali ;
Shariatzadeh, Nastaran ;
Gharavi, A'azam ;
Heravifard, Soudabeh ;
Tayebinejad, Nima ;
Salekzamani, Shabnam ;
Zahedirad, Malihe .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2011, 93 (04) :764-771
[40]   VITAMIN-D DEFICIENCY INHIBITS PANCREATIC-SECRETION OF INSULIN [J].
NORMAN, AW ;
FRANKEL, BJ ;
HELDT, AM ;
GRODSKY, GM .
SCIENCE, 1980, 209 (4458) :823-825